ADL 21294

Drug Profile

ADL 21294

Alternative Names: ADL 2-1294; Loperamide ophthalmic - Adolor; Loperamide topical - Adolor

Latest Information Update: 31 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator University of California, San Diego
  • Class Antidiarrhoeals; Piperidines
  • Mechanism of Action Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Dental pain; Ocular pain; Pain; Pruritus

Most Recent Events

  • 31 Aug 2007 Discontinued - Preclinical for Pain in USA (Intra-articular)
  • 10 Jul 2006 No development reported - Preclinical for Pain in USA (Intra-articular)
  • 26 Sep 2003 Discontinued - Phase-II for Ocular pain in USA (Ophthalmic)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top